Clinical Trial Update: Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients

View source ↗

Summary

A clinical trial evaluating posaconazole for prophylaxis of pulmonary fungal infection in hematopoietic stem cell transplantation patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fungal Infection

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Pulmonary Fungal Infection | Status: COMPLETED